The short answer
Soy protein taken close to levothyroxine can interfere with treatment, but soy products are not all equivalent. A small study of one soy-isoflavone supplement found no meaningful change in drug exposure. Review the actual product and use a consistent schedule rather than relying on a universal one-hour rule.
What this answer covers
Soy-derived oral foods and supplements with oral levothyroxine. Protein drinks, soy-based infant formula and isolated isoflavones are distinguished; Glycine max alone does not identify the preparation.
- Supplement or preparation
- soy
- Medication ingredient
- levothyroxine
What is known about soy protein?
One patient taking a soy protein drink immediately after levothyroxine needed a high dose to achieve thyroid-cancer suppression. Separating the drink was associated with a lower dose requirement. This is a useful clinical signal, though one case does not establish the effect in every patient.
Are isoflavone capsules different?
Yes. A twelve-person crossover study found comparable levothyroxine exposure when one 60 mg soy-isoflavone supplement was taken together with the medicine or six hours later. The result applies to that tested formulation and does not establish that soy protein drinks behave the same way.
What timing should I discuss?
The 2025 European Thyroid Association suggests taking levothyroxine at least four hours before soy, with soy protein supplements delayed more than four hours. These are conservative clinical suggestions, not a universal experimentally proven interval. The product and treatment target matter.
What else should I tell my clinician?
Report changes in soy intake when reviewing thyroid tests. Do not mix a crushed SYNTHROID dose into soy-based infant formula. Infant feeding and dosing require the child’s clinician; adult supplement studies cannot establish a feeding plan.
Evidence and practical considerations
Absorption & effectiveness
Soy protein taken close to levothyroxine can interfere with treatment, but soy products are not all equivalent. A small study of one soy-isoflavone supplement found no meaningful change in drug exposure. Review the actual product and use a consistent schedule rather than relying on a universal one-hour rule.
- Exact scope
- Soy-derived oral foods and supplements with oral levothyroxine. Protein drinks, soy-based infant formula and isolated isoflavones are distinguished; Glycine max alone does not identify the preparation. with Levothyroxine active moiety, RxCUI 10582 (IN), supplied as oral levothyroxine sodium tablets. The DailyMed active-ingredient table explicitly connects the sodium salt to levothyroxine. No extrapolation to injectable hormone or another thyroid drug.
- Medication form and route
- oral levothyroxine tablets with oral supplement
What remains uncertain
- Evidence includes a single protein-drink case and a small product-specific isoflavone study. The proposed spacing guidance is not proof of equal risk across all soy foods, formulas and extracts.
Factors that may matter: exact product and dose; thyroid condition and treatment target; administration routine.
Read the supporting source summaries
Source 1: regulatory prescribing information
rxabbvie.com · Source check Sep 10, 2026
Population: Patients prescribed oral levothyroxine sodium tablets.
Addresses fasting administration, interfering antacids and food, thyroid monitoring and the risks of over- or undertreatment.
How this applies: Soy-derived oral foods and supplements with oral levothyroxine. Protein drinks, soy-based infant formula and isolated isoflavones are distinguished; Glycine max alone does not identify the preparation. The source supports medication administration and monitoring, not an isolated effect for every supplement.
Does not quantify every supplement interaction; recommendations for these tablets do not establish identical behavior for liquid or injected levothyroxine.
Source 2: primary clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: One 45-year-old woman after thyroidectomy and radioiodine treatment for thyroid cancer.
Separating the drink was associated with achieving the intended thyroid suppression at a lower levothyroxine dose.
How this applies: Soy-derived oral foods and supplements with oral levothyroxine. Protein drinks, soy-based infant formula and isolated isoflavones are distinguished; Glycine max alone does not identify the preparation. Apply only the preparation, population and limitations recorded for this source.
Single case with a suppression-treatment target; the abstract does not establish a universal interval or test isolated isoflavones.
Source 3: primary clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Twelve postmenopausal women receiving stable oral levothyroxine replacement.
Peak and total exposure ratios met the study’s bioequivalence criteria.
How this applies: Soy-derived oral foods and supplements with oral levothyroxine. Protein drinks, soy-based infant formula and isolated isoflavones are distinguished; Glycine max alone does not identify the preparation. Apply only the preparation, population and limitations recorded for this source.
Small, formulation-specific crossover study; does not establish equivalence for soy protein drinks, all soy foods or long-term outcomes.
Source 4: professional society clinical guideline
pure.eur.nl · Source check Sep 10, 2026
Population: People treated for hypothyroidism.
Provides product-specific separation suggestions and recommends reviewing dietary interference when thyroid control changes.
How this applies: Soy-derived oral foods and supplements with oral levothyroxine. Protein drinks, soy-based infant formula and isolated isoflavones are distinguished; Glycine max alone does not identify the preparation. Apply only the preparation, population and limitations recorded for this source.
Clinical guidance synthesizing evidence and expert judgment; the table is not a trial demonstrating the minimum effective interval for every product.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original research, current labeling and relevant guidance checked. Consumer article written with preparation-specific limits and proposed corrections to checker statements. | |
| Research summary published |
Article revision: 0bd3ef40188e1294
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.